Evidence map›Paper›PMID 34979543›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2022

Tobacco Use and Treatment of Tobacco Dependence Among People With Human Immunodeficiency Virus: A Practical Guide for Clinicians.

Krishna P Reddy, Gina R Kruse, Stephanie Lee, Jonathan Shuter, Nancy A Rigotti

Open access · bronzeAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Optimizing the Implementation of Tobacco Treatment for People with HIV: A Pilot Study.International journal of environmental research and public health · 2022
    Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Krishna P ReddyTobacco Research and Treatment Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Gina R KruseTobacco Research and Treatment Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Stephanie LeeMedical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Jonathan ShuterDepartment of Medicine and Department of Epidemiology and Population Health, Division of Infectious Diseases, Albert Einstein College of Medicine, Bronx, New York, USA.
Nancy A RigottiTobacco Research and Treatment Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Harvard University · USMassachusetts General Hospital · USAlbert Einstein College of Medicine · US

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI KENNETH H MAYER · 2004 to 2026
$94.4M
Varenicline and mobile behavioral assistance for tobacco cessation in HIV care in India.U01CA261614 · NCI · UNIVERSITY OF COLORADO DENVER · PI KRUSE, GINA RAE · 2021 to 2025
$3.4M
Tobacco Use and Cessation, HIV, and TB in South Africa: Clinical and Economic Outcomes (Clinical and public health approaches to tobacco cessation in South Africa supplement)R01DA050482 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI REDDY, KRISHNA P · 2020 to 2024
$3.4M
RCT of An Internet Cessation Program Plus Online Social Network for HIV + SmokersR01CA192954 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI SHUTER, JONATHAN, STANTON, CASSANDRA A · 2015 to 2019
$3.3M
Optimizing Smoking Cessation interventions for PLWH in Nairobi, KenyaR01CA225419 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI HIMELHOCH, SETH S, SHUTER, JONATHAN · 2018 to 2022
$3.2M
Clinical and Economic Outcomes of HIV, Cigarette Smoking, and Smoking Cessation InterventionsK01DA042687 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI REDDY, KRISHNA P · 2016 to 2020
$929k
NCI NIH HHS R01 CA192954NCI NIH HHS R01 CA225419NCI NIH HHS U01 CA261614NIAID NIH HHS P30 AI060354NIDA NIH HHS K01 DA042687NIDA NIH HHS R01 DA050482
6 · The paper itself

Abstract

More than 40% of people with human immunodeficiency virus (PWH) in the United States smoke tobacco cigarettes. Among those on antiretroviral therapy, smoking decreases life expectancy more than human immunodeficiency virus (HIV) itself. Most PWH who smoke want to quit, but tobacco dependence treatment has not been widely integrated into HIV care. This article summarizes the epidemiology of tobacco use among PWH, health consequences of tobacco use and benefits of cessation in PWH, and studies of treatment for tobacco dependence among the general population and among PWH. We provide practical guidance for providers to treat tobacco dependence among PWH. A 3-step Ask-Advise-Connect framework includes asking about tobacco use routinely during clinical encounters, advising about tobacco cessation with emphasis on the benefits of cessation, and actively connecting patients to cessation treatments, including prescription of pharmacotherapy (preferably varenicline) and direct connection to behavioral interventions via telephone quitline or other means to increase the likelihood of a successful quit attempt.

Indexed as

HIV InfectionsSmoking CessationTobacco Use DisorderHIVHumansTobacco UseTobacco Use Cessation DevicesUnited Statesbehavioral therapycessationHIVpharmacotherapytobacco smoking

Identifiers

PMID34979543
PMCPMC9427148
OpenAlexW4205709271

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.